DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 142 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q4 2017. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $949,000 | – | 50,726 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,452,235 | $48,347,000 | 7.21% |
| Avidity Partners Management LP | 780,000 | $4,462,000 | 2.81% |
| Bain Capital Public Equity Management II, LLC | 3,559,547 | $20,361,000 | 1.93% |
| Senvest Management, LLC | 3,988,889 | $22,816,000 | 1.55% |
| Chicago Capital, LLC | 3,999,740 | $22,879,000 | 1.40% |
| Rhenman & Partners Asset Management AB | 1,080,000 | $6,178,000 | 0.68% |
| JACKSON SQUARE CAPITAL, LLC | 143,180 | $819,000 | 0.47% |
| RA Capital Management | 2,365,912 | $13,533,000 | 0.41% |
| Crow Point Partners, LLC | 35,617 | $199,000 | 0.31% |
| Rock Springs Capital Management LP | 1,575,000 | $9,009,000 | 0.28% |